Literature DB >> 6847220

Progressive vaccinia associated with combined variable immunodeficiency.

J T Keane, K James, M L Blankenship, R W Pearson.   

Abstract

Progressive vaccinia developed in a previously healthy woman following smallpox vaccination and was successfully treated with vaccinia immune human globulin and methisazone. Immunologic evaluation over the next 4 1/2 years revealed evidence for combined variable immunodeficiency with increased numbers of circulating OKT 8 positive (suppressor-cytotoxic T) cells and the virtual absence of OKT 4 positive (helper-inducer T) cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847220

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  Phage antibodies neutralize vaccinia virus.

Authors:  N V Tikunova; E F Belanov; V V Morozova; T A Batanova; N I Bormotov; L G Ovechkina; A A Ilyichev; L S Sandakhchiev
Journal:  Dokl Biochem Biophys       Date:  2002 Jan-Feb       Impact factor: 0.788

2.  The need for characterization of pathogenicity genes of recombinant DNA viruses used as human vaccines.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1987-11       Impact factor: 2.332

3.  Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections.

Authors:  Yuhong Xiao; Stuart N Isaacs
Journal:  Viruses       Date:  2010-10       Impact factor: 5.048

4.  Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.

Authors:  Lili Deng; Jun Fan; Yuedi Ding; Jue Zhang; Bin Zhou; Yi Zhang; Biao Huang
Journal:  Oncotarget       Date:  2017-06-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.